InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the complete record of transactions filed by Kolean Chad J. Director active across 1 company, notably Cellectar Biosciences, Inc.. Aggregated, 2 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €21k. Activity tracked since 8 December 2023. The latest transaction was filed on 2 July 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations